查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1400644

心血管臨床試驗市場依階段（I、II、III 和IV 期）、研究設計（介入性、觀察性）、適應症（冠狀動脈疾病、心律不整、缺血性心臟病）、最終用途、2023- 2032 年全球預測

Cardiovascular Clinical Trials Market By Phase (Phase I, II, III, & IV), Study design (Interventional, Observational), Indication (Coronary Artery Disease, Cardiac Arrhythmia, Ischemic Heart Disease), End-use, Global Forecast 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

由於生活方式相關因素和人口老化導致心血管疾病盛行率不斷增加，預計 2023 年至 2032 年心血管臨床試驗市場的CAGR將超過 6.1%。根據世界心臟聯合會的報告，全球心血管死亡人數從1990年的1,210萬人激增至2021年的2,050萬人。

此外，醫療技術的進步和對心血管健康的了解推動了對更複雜和更有針對性的臨床試驗的需求。穿戴式裝置和遠端監控等新興技術增強了資料收集，並更全面地了解患者對介入措施的反應。這項技術進步不僅簡化了試驗流程，也吸引了心血管研究的投資。

心血管臨床試驗產業根據階段、研究設計、適應症、最終用途和地區進行細分。

在未滿足的關鍵醫療需求和對創新治療解決方案不斷成長的需求的支持下，預計到 2032 年，肺動脈高壓症候群 (PAHS) 領域將大幅成長。 PAHS 帶來了嚴重且常常危及生命的挑戰，促使人們更加關注透過臨床試驗開發有效的治療方法。隨著科學見解和技術的進步為標靶治療提供了新途徑，製藥公司正在努力解開肺動脈高壓的複雜性。

醫療器材製造商細分市場預計將在 2023 年和 2032 年實現顯著的CAGR，這得益於其在開發和測試創新心血管技術方面的重要作用。隨著醫療設備的進步不斷革新心血管疾病的診斷、監測和治療，製造商積極參與臨床試驗以驗證其產品的安全性和有效性。監管機構越來越重視基於證據的實踐以及嚴格測試的需求將有利於該細分市場的成長。

由於醫療基礎設施不斷發展以及患者群體不斷擴大，亞太地區心血管臨床試驗產業佔有率將在 2023 年至 2032 年間大幅增加。心血管疾病的流行增加了對有針對性的干涉措施的需求，導致針對區域健康細微差別的試驗出現轉變。此外，製藥公司、研究機構和政府機構之間的合作舉措正在蓬勃發展，利用該地區遺傳和生活方式的豐富多樣性來推進心血管研究，推動該地區市場的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：心血管臨床試驗市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 全球心血管疾病負擔不斷增加
      • 合約研究組織 (CRO) 數量不斷增加
      • 增加臨床試驗研發支出
    • 產業陷阱與挑戰
      • 病患招募和保留挑戰
    • 成長潛力分析
    • 按階段
    • 透過研究設計
    • 按指示
    • 按最終用途
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：心血管臨床試驗市場估計與預測：按階段，2018-2032

  • 主要動向：分相
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 6 章：心血管臨床試驗市場估計與預測：按研究設計，2018-2032

  • 主要動力向：透過研究設計
  • 介入治療
  • 觀察性
  • 擴大訪問範圍

第 7 章：心血管臨床試驗市場估計與預測：按適應症分類，2018-2032 年

  • 主要動向：依指示
  • 腦血管疾病
  • 冠狀動脈疾病
  • 高血壓心臟病
  • 心律不整
  • 發炎性心臟病
  • 肺動脈高壓症候群
  • 缺血性心臟病
  • 心臟衰竭
  • 其他適應症

第 8 章：心血管臨床試驗市場估計與預測：按最終用途，2018-2032 年

  • 主要動向：依最終用途
  • 生物技術和製藥公司
  • 醫療器材製造商
  • 合約研究組織（CRO）
  • 其他最終用戶

第 9 章：心血管臨床試驗市場估計與預測：按地區，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Eli Lilly & Company
  • IQVIA Inc
  • Worldwide Clinical Trials
  • ICON plc
  • Thermo Fisher Scientific (PPD Inc)
  • Syneos Health
  • Medpace, Inc.
  • Veeda Clinical Research
  • WuXi AppTech
  • Pfizer
  • Merck & Co
Product Code: 7404

Cardiovascular Clinical Trials Market is projected to grow at a CAGR of over 6.1% over 2023-2032, owing to the increasing prevalence of cardiovascular diseases due to lifestyle related factors and aging population. As per the reports from World Heart Federation, the cardiovascular deaths surged from 12.1 million in 1990 to 20.5 million across the globe in 2021.

Additionally, advancements in medical technology and the understanding of cardiovascular health have propelled the need for more sophisticated and targeted clinical trials. Emerging technologies, such as wearable devices and remote monitoring, enhance data collection and provide a more comprehensive understanding of patient responses to interventions. This technological evolution not only streamlines trial processes but also attracts investment in cardiovascular research.

Cardiovascular clinical trials industry is segmented based on phase, study design, indication, end-use, and region.

Pulmonary arterial hypertension syndrome (PAHS) segment is anticipated to witness substantial growth through 2032, backed by critical unmet medical needs and the rising demand for innovative therapeutic solutions. PAHS poses a severe and often life-threatening challenge, prompting increased focus on developing effective treatments through clinical trials. As advancements in scientific insight and technology provide new avenues for targeted therapies, pharmaceutical companies are directing their efforts toward unraveling the complexities of pulmonary arterial hypertension.

Medical devices manufacturers segment is anticipated to observe a significant CAGR during 2023 and 2032, favored by its vital role in developing and testing innovative cardiovascular technologies. As advancements in medical devices continue to revolutionize the diagnosis, monitoring, and treatment of cardiovascular conditions, manufacturers are actively engaged in clinical trials to validate the safety and efficacy of their products. Regulatory bodies' increasing emphasis on evidence-based practices and the need for rigorous testing will favor the segment growth.

Asia Pacific cardiovascular clinical trials industry share will grow substantially between 2023 and 2032, attributed to the evolving healthcare infrastructure, coupled with an expanding patient pool. The prevalence of cardiovascular diseases amplifies the demand for targeted interventions, leading to a turnaround in trials focused on regional health nuances. Furthermore, collaborative initiatives between pharmaceutical companies, research institutions, and government bodies are gaining momentum, harnessing the rich diversity in the region's genetic and lifestyle profiles to advance cardiovascular research, pushing the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast Calculation
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Cardiovascular clinical trials industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Phase trends
    • 2.1.4 Study design trends
    • 2.1.5 Indication trends
    • 2.1.6 End-use trends

Chapter 3 Cardiovascular Clinical Trials Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising burden of cardiovascular diseases globally
      • 3.2.1.2 Increasing number of contract research organizations (CROs)
      • 3.2.1.3 Increasing R&D expenditure towards clinical trials
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Patient recruitment and retention challenges
    • 3.2.3 Growth potential analysis
    • 3.2.4 By phase
    • 3.2.5 By study design
    • 3.2.6 By indication
    • 3.2.7 By end use
  • 3.3 COVID-19 impact analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Cardiovascular Clinical Trials Market Estimates and Forecast, By Phase, 2018-2032 (USD Million)

  • 5.1 Key trends, by phase
  • 5.2 Phase I
  • 5.3 Phase II
  • 5.4 Phase III
  • 5.5 Phase IV

Chapter 6 Cardiovascular Clinical Trials Market Estimates and Forecast, By Study Design, 2018-2032 (USD Million)

  • 6.1 Key trends, by study design
  • 6.2 Interventional
  • 6.3 Observational
  • 6.4 Expanded access

Chapter 7 Cardiovascular Clinical Trials Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

  • 7.1 Key trends, by indication
  • 7.2 Cerebrovascular disease
  • 7.3 Coronary artery disease
  • 7.4 Hypertensive heart disease
  • 7.5 Cardiac arrhythmia
  • 7.6 Inflammatory heart disease
  • 7.7 Pulmonary arterial hypertension syndrome
  • 7.8 Ischemic heart disease
  • 7.9 Heart failure
  • 7.10 Other indications

Chapter 8 Cardiovascular Clinical Trials Market Estimates and Forecast, By End Use, 2018-2032 (USD Million)

  • 8.1 Key trends, by end-use
  • 8.2 Biotechnology and pharmaceutical companies
  • 8.3 Medical devices manufacturers
  • 8.4 Contract research organization (CRO)
  • 8.5 Other end users

Chapter 9 Cardiovascular Clinical Trials Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Eli Lilly & Company
  • 10.2 IQVIA Inc
  • 10.3 Worldwide Clinical Trials
  • 10.4 ICON plc
  • 10.5 Thermo Fisher Scientific (PPD Inc)
  • 10.6 Syneos Health
  • 10.7 Medpace, Inc.
  • 10.8 Veeda Clinical Research
  • 10.9 WuXi AppTech
  • 10.10 Pfizer
  • 10.11 Merck & Co

Data Tables

  • TABLE 1 Market revenue, by phase (2022)
  • TABLE 2 Market revenue, by study design (2022)
  • TABLE 3 Market revenue, by indication (2022)
  • TABLE 4 Market revenue, by end-use (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global cardiovascular clinical trials market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global cardiovascular clinical trials market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 9 Global cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 10 Global cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 11 Global cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 12 Global cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 13 Global cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 14 Global cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 15 Global cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 16 Industry impact forces
  • TABLE 17 Phase I market size, 2018 - 2022 (USD Million)
  • TABLE 18 Phase I market size, 2023 - 2032 (USD Million)
  • TABLE 19 Phase II market size, 2018 - 2022 (USD Million)
  • TABLE 20 Phase II market size, 2023 - 2032 (USD Million)
  • TABLE 21 Phase III market size, 2018 - 2022 (USD Million)
  • TABLE 22 Phase III market size, 2023 - 2032 (USD Million
  • TABLE 23 Phase IV market size, 2018 - 2022 (USD Million)
  • TABLE 24 Phase IV market size, 2023 - 2032 (USD Million
  • TABLE 25 Interventional market size, 2018 - 2022 (USD Million)
  • TABLE 26 Interventional market size, 2023 - 2032 (USD Million
  • TABLE 27 Observational market size, 2018 - 2022 (USD Million)
  • TABLE 28 Observational market size, 2023 - 2032 (USD Million
  • TABLE 29 Expanded access market size, 2018 - 2022 (USD Million)
  • TABLE 30 Expanded access market size, 2023 - 2032 (USD Million)
  • TABLE 31 Cerebrovascular disease market size, 2018 - 2022 (USD Million)
  • TABLE 32 Cerebrovascular disease market size, 2023 - 2032 (USD Million)
  • TABLE 33 Coronary artery disease market size, 2018 - 2022 (USD Million)
  • TABLE 34 Coronary artery disease market size, 2023 - 2032 (USD Million)
  • TABLE 35 Hypertensive heart disease market size, 2018 - 2022 (USD Million)
  • TABLE 36 Hypertensive heart disease market size, 2023 - 2032 (USD Million)
  • TABLE 37 Cardiac arrhythmia market size, 2018 - 2022 (USD Million)
  • TABLE 38 Cardiac arrhythmia market size, 2023 - 2032 (USD Million)
  • TABLE 39 Inflammatory heart disease market size, 2018 - 2022 (USD Million)
  • TABLE 40 Inflammatory heart disease market size, 2023 - 2032 (USD Million)
  • TABLE 41 Pulmonary arterial hypertension syndrome market size, 2018 - 2022 (USD Million)
  • TABLE 42 Pulmonary arterial hypertension syndrome market size, 2023 - 2032 (USD Million)
  • TABLE 43 Ischemic heart disease market size, 2018 - 2022 (USD Million)
  • TABLE 44 Ischemic heart disease market size, 2023 - 2032 (USD Million)
  • TABLE 45 Heart failure market size, 2018 - 2022 (USD Million)
  • TABLE 46 Heart failure market size, 2023 - 2032 (USD Million)
  • TABLE 47 Stroke market size, 2018 - 2022 (USD Million)
  • TABLE 48 Stroke market size, 2023 - 2032 (USD Million)
  • TABLE 49 Other indications market size, 2018 - 2022 (USD Million)
  • TABLE 50 Other indications market size, 2023 - 2032 (USD Million)
  • TABLE 51 Biotechnology and pharmaceutical companies market size, 2018 - 2022 (USD Million)
  • TABLE 52 Biotechnology and pharmaceutical companies market size, 2023 - 2032 (USD Million)
  • TABLE 53 Medical device manufacturers market size, 2018 - 2022 (USD Million)
  • TABLE 54 Medical device manufacturers market size, 2023 - 2032 (USD Million)
  • TABLE 55 Contract research organization (CRO) market size, 2018 - 2022 (USD Million)
  • TABLE 56 Contract research organization (CRO) size, 2023 - 2032 (USD Million)
  • TABLE 57 Other end-users market size, 2018 - 2022 (USD Million)
  • TABLE 58 Other end-users market size, 2023 - 2032 (USD Million)
  • TABLE 59 North America cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
  • TABLE 60 North America cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
  • TABLE 61 North America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 62 North America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 63 North America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 64 North America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 65 North America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 66 North America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 67 North America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 68 North America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 69 U.S. cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 70 U.S. cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 71 U.S. cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 72 U.S. cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 73 U.S. cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 74 U.S. cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 75 U.S. cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 76 U.S. cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 77 Canada cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 78 Canada cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 79 Canada cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 80 Canada cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 81 Canada cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 82 Canada cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 83 Canada cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 84 Canada cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 85 Europe cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
  • TABLE 86 Europe cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
  • TABLE 87 Europe cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 88 Europe cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 89 Europe cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 90 Europe cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 91 Europe cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 92 Europe cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 93 Europe cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 94 Europe cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 95 Germany cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 96 Germany cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 97 Germany cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 98 Germany cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 99 Germany cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 100 Germany cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 101 Germany cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 102 Germany cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 103 UK cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 104 UK cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 105 UK cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 106 UK cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 107 UK cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 108 UK cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 109 UK cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 110 UK cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 111 France cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 112 France cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 113 France cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 114 France cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 115 France cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 116 France cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 117 France cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 118 France cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 119 Spain cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 120 Spain cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 121 Spain cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 122 Spain cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 123 Spain cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 124 Spain cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 125 Spain cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 126 Spain cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 127 Italy cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 128 Italy cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 129 Italy cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 130 Italy cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 131 Italy cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 132 Italy cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 133 Italy cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 134 Italy cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 137 Rest of Europe cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 138 Rest of Europe cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Europe cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Europe cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Europe cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Europe cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 149 Asia Pacific cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 150 Asia Pacific cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 151 Asia Pacific cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 152 Asia Pacific cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 153 China cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 154 China cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 155 China cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 156 China cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 157 China cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 158 China cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 159 China cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 160 China cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 161 Japan cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 162 Japan cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 163 Japan cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 164 Japan cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 165 Japan cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 166 Japan cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 167 Japan cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 168 Japan cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 169 India cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 170 India cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 171 India cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 172 India cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 173 India cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 174 India cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 175 India cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 176 India cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 177 Australia cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 178 Australia cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 179 Australia cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 180 Australia cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 181 Australia cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 182 Australia cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 183 Australia cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 184 Australia cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 185 Rest of Asia Pacific cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 186 Rest of Asia Pacific cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 187 Rest of Asia Pacific cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 188 Rest of Asia Pacific cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 193 Latin America cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
  • TABLE 194 Latin America cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
  • TABLE 195 Latin America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 196 Latin America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 203 Brazil cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 204 Brazil cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 205 Brazil cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 206 Brazil cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 211 Mexico cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 212 Mexico cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 213 Mexico cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 214 Mexico cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 219 Rest of Latin America cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 220 Rest of Latin America cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 221 Rest of Latin America cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 222 Rest of Latin America cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 227 Middle East & Africa cardiovascular clinical trials market size, by country, 2018 - 2022 (USD Million)
  • TABLE 228 Middle East & Africa cardiovascular clinical trials market size, by country, 2023 - 2032 (USD Million)
  • TABLE 229 Middle East & Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 230 Middle East & Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 237 South Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 238 South Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 239 South Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 240 South Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 243 South Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 244 South Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 245 Saudi Arabia cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 246 Saudi Arabia cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 247 Saudi Arabia cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 248 Saudi Arabia cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 249 Saudi Arabia cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 250 Saudi Arabia cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 251 Saudi Arabia cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 252 Saudi Arabia cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 253 Rest of Middle East & Africa cardiovascular clinical trials market size, by phase, 2018 - 2022 (USD Million)
  • TABLE 254 Rest of Middle East & Africa cardiovascular clinical trials market size, by phase, 2023 - 2032 (USD Million)
  • TABLE 255 Rest of Middle East & Africa cardiovascular clinical trials market size, by study design, 2018 - 2022 (USD Million)
  • TABLE 256 Rest of Middle East & Africa cardiovascular clinical trials market size, by study design, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East & Africa cardiovascular clinical trials market size, by indication, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East & Africa cardiovascular clinical trials market size, by indication, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East & Africa cardiovascular clinical trials market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East & Africa cardiovascular clinical trials market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Cardiovascular clinical trials market industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by phase
  • FIG 8 Growth potential analysis, by study design
  • FIG 9 Growth potential analysis, by indication
  • FIG 10 Growth potential analysis, by end-use
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix, 2022
  • FIG 16 Strategic dashboard, 2022